Maintenance of disease chronicity by dysregulated macrophage-epithelial cell interactions

J. Allen (Edinburgh, United Kingdom)

Source: ERS Research Seminar 2016
Number: 9
Disease area: Airway diseases

PDF journal article, handout or slidesPDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Allen (Edinburgh, United Kingdom). Maintenance of disease chronicity by dysregulated macrophage-epithelial cell interactions. ERS Research Seminar 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cell-matrix interactions in chronic lung disease
Source: Virtual Congress 2021 – Repair and regeneration in chronic lung disease and lung cancer
Year: 2021


Cell-matrix interactions in chronic lung disease
Source: ERS Lung Science Conference 2021
Year: 2021



Signalling and transcriptional regulation in inflammatory and immune cells: importance in lung biology and disease
Source: Eur Respir J 2005; 26: 762-763
Year: 2005


Identification of an IL-6-dependent macrophage population required for driving fibrotic disease
Source: International Congress 2019 – Pathogenesis and prognosis of interstitial lung disease of known origin
Year: 2019



The role of increasing TIM3 on T cells in patients with nontuberculous mycobacterial lung disease: from immune cell dysfunction to clinical severity
Source: Virtual Congress 2021 – Advances in the diagnosis of tuberculosis, multidrug-resistant tuberculosis and nontuberculous mycobacterial disease
Year: 2021



Genetic deletion of SLPI promotes inflammatory cell recruitment in a model of chronic lung disease
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Immune system dysregulation in chronic lung disease
Source: Eur Respir J 2011; 38: 500-501
Year: 2011


Host–microbe cross-talk in the lung microenvironment: implications for understanding and treating chronic lung disease
Source: Eur Respir J, 56 (2) 1902320; 10.1183/13993003.02320-2019
Year: 2020



T-helper cell type-2 regulation in allergic disease
Source: Eur Respir J 2005; 26: 1119-1137
Year: 2005



Circulating MDSC modulate IPF progression by orchestrating immunosuppressive and pro-fibrotic networks
Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases
Year: 2018

Cellular mechanisms underlying CCSP SNP association with chronic airway diseases
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

Dysregulated mitochondrial integrity associated with lamin B1 reduction is involved in cellular senescence progression in COPD pathogenesis.
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018



Inflammatory cell microlocalisation and airway dysfunction: cause and effect?
Source: Eur Respir J 2007; 30: 1043-1056
Year: 2007



Is soluble MICA facilitating tumor immune evasion in patients with COPD?
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008


Human rhinovirus 16 infection of human macrophages significantly impairs their phagocytic and regulatory functions: implications in understanding chronic inflammatory lung disease
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017



Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020


Cellular interactions in the pathogenesis of interstitial lung diseases
Source: Eur Respir Rev 2015; 24: 102-114
Year: 2015